Postoperative Euglycemic Ketoacidosis Frequency in Sodium-Glucose Cotransporter-2 Inhibitor Users

Condition(s) studied

Study summary

The goal of this observational study is to determine the frequency of postoperative euglycemic diabetic ketoacidosis (EDKA) in patients receiving Sodium- Glucose Cotransporter-2 (SGLT-2) inhibitors. The main questions it aims to answer are:Is the use of SGLT-2 inhibitors a factor that increases the incidence of euglycemic diabetic ketoacidosis in patients in the perioperative period or what conditions in the perioperative period cause EDKA in patients on SGLT-2 inhibitors?

Eligibility

Primary outcome measure(s)

• The incidence of diabetic ketoacidosis in Postoperative care unit among patients who receives SGLT-2 inhibitor — 24 hours after surgery
  Patients receiving SGLT-2 inhibitors will be follow up in postoperative care unit.

Trial sites (1)

More Kocaeli City Hospital trials in Turkey

Other trials for the same condition